Hyeokjun Yun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hyeokjun Yun has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Jae Kyung Kim
Department of Biomedical Laboratory Science, College of Health Sciences, Dankook University, Cheonan-si 31116, Republic of Korea
4 shared publications - Bo Kyeung Jung
Department of Laboratory Medicine, College of Medicine, Dankook University, Cheonan 31116, Republic of Korea
1 shared publication - Jae-Sik Jeon
Department of Biomedical Laboratory Science, College of Health Sciences, Dankook University, Cheonan-si 31116, Republic of Korea
1 shared publication - Jong Wan Kim
Department of Laboratory Medicine, Dankook University College of Medicine, Cheonan, Korea
1 shared publication - Joowon Park
Department of Laboratory Medicine, Dankook University College of Medicine, Cheonan, Korea
1 shared publication
Latest Publications
- Open Access
Plasma Beta-Amyloid and Metabolic Biomarkers: Age- and Sex-Stratified Analyses Suggest Limited Population-Level Associations
Background and Objectives: This study examined the relationships between plasma beta-amyloid levels and systemic inflammatory, thyroid, and lipid biomarkers using complementary analytical approaches in a cross-sectional cohort undergoing plasma OAβ and laboratory testing. Materials and Methods: Plasma beta-amyloid, high-sensitivity C-reactive protein (hsCRP), thyroid hormones (TSH and FT4), and lipid profiles (HDL, LDL, and TG) were analyzed. Pearson correlation analyses assessed continuous associations, and one-way analysis of variance (ANOVA) compared biomarker distributions across plasma beta-amyloid categories (low, boundary, high), with additional stratification by age and sex. Multivariable linear regression models adjusted for age and sex evaluated the independence of observed associations. Results: Overall, plasma beta-amyloid showed limited associations with metabolic biomarkers at the population level. A weak inverse correlation with hsCRP was observed in unadjusted analyses in the low group and in males, whereas other biomarkers showed no consistent associations. Additional correlations emerged in selected subgroups but were heterogeneous, based on small samples, and interpreted as exploratory. ANOVA-based comparisons showed no significant differences across plasma beta-amyloid categories in the overall cohort or major strata. Although HDL showed subgroup-specific variation, these associations were not retained after adjustment. Conclusions: Assay-based plasma beta-amyloid categorization was not associated with uniform systemic metabolic alterations. Common inflammatory, thyroid, and lipid biomarkers were not robust population-level correlates and, when present in subgroups, likely reflected context-dependent rather than stable associations.
Open AccessPlasma Beta-Amyloid and Metabolic Biomarkers: Age- and Sex-Stratified Analyses Suggest Limited Population-Level Associations
Background and Objectives: This study examined the relationships between plasma beta-amyloid levels and systemic inflammatory, thyroid, and lipid biomarkers using complementary analytical approaches in a cross-sectional cohort undergoing plasma OAβ and laboratory testing. Materials and Methods: Plasma beta-amyloid, high-sensitivity C-reactive protein (hsCRP), thyroid hormones (TSH and FT4), and lipid profiles (HDL, LDL, and TG) were analyzed. Pearson correlation analyses assessed continuous associations, and one-way analysis of variance (ANOVA) compared biomarker distributions across plasma beta-amyloid categories (low, boundary, high), with additional stratification by age and sex. Multivariable linear regression models adjusted for age and sex evaluated the independence of observed associations. Results: Overall, plasma beta-amyloid showed limited associations with metabolic biomarkers at the population level. A weak inverse correlation with hsCRP was observed in unadjusted analyses in the low group and in males, whereas other biomarkers showed no consistent associations. Additional correlations emerged in selected subgroups but were heterogeneous, based on small samples, and interpreted as exploratory. ANOVA-based comparisons showed no significant differences across plasma beta-amyloid categories in the overall cohort or major strata. Although HDL showed subgroup-specific variation, these associations were not retained after adjustment. Conclusions: Assay-based plasma beta-amyloid categorization was not associated with uniform systemic metabolic alterations. Common inflammatory, thyroid, and lipid biomarkers were not robust population-level correlates and, when present in subgroups, likely reflected context-dependent rather than stable associations.
- Open Access
Multivariate Assessment of Thyroid, Lipid, and Inflammatory Profiles by HBV Status and Viral Load: Age- and Sex-Specific Findings
Chronic hepatitis B virus (HBV) infection may influence extrahepatic systems, including endocrine and lipid regulation. In this cross-sectional study, 186 adults were stratified by HBV DNA status and viral load to examine thyroid function, systemic inflammation, and lipid metabolism, with further analyses by age and sex. Thyroid-stimulating hormone (TSH, a pituitary regulator of thyroid function) levels were significantly lower in HBsAg-positive individuals compared with controls; however, this association was attenuated after stratification by viral load, indicating that the relationship is not unequivocally independent of HBV DNA levels, as free thyroxine (FT4, the circulating thyroid hormone reflecting gland activity) levels remained stable. Lipid profiles displayed demographic-specific patterns: males with high viral load exhibited lower HDL cholesterol, whereas younger HBV-positive individuals showed higher LDL cholesterol. CRP levels were unaffected by HBV status or viral load, aligning with the absence of systemic inflammation in early or inactive disease stages. Age was a major determinant across biomarkers, with complex interactions involving sex and viral load. These findings indicate subtle but clinically relevant extrahepatic effects of HBV infection and underscore the need for personalized monitoring and longitudinal studies to clarify metabolic and cardiovascular implications. These subgroup trends should be interpreted with caution given the absence of BMI, liver enzyme, fibrosis, medication, and comorbidity data in this retrospective cohort.
Open AccessMultivariate Assessment of Thyroid, Lipid, and Inflammatory Profiles by HBV Status and Viral Load: Age- and Sex-Specific Findings
Chronic hepatitis B virus (HBV) infection may influence extrahepatic systems, including endocrine and lipid regulation. In this cross-sectional study, 186 adults were stratified by HBV DNA status and viral load to examine thyroid function, systemic inflammation, and lipid metabolism, with further analyses by age and sex. Thyroid-stimulating hormone (TSH, a pituitary regulator of thyroid function) levels were significantly lower in HBsAg-positive individuals compared with controls; however, this association was attenuated after stratification by viral load, indicating that the relationship is not unequivocally independent of HBV DNA levels, as free thyroxine (FT4, the circulating thyroid hormone reflecting gland activity) levels remained stable. Lipid profiles displayed demographic-specific patterns: males with high viral load exhibited lower HDL cholesterol, whereas younger HBV-positive individuals showed higher LDL cholesterol. CRP levels were unaffected by HBV status or viral load, aligning with the absence of systemic inflammation in early or inactive disease stages. Age was a major determinant across biomarkers, with complex interactions involving sex and viral load. These findings indicate subtle but clinically relevant extrahepatic effects of HBV infection and underscore the need for personalized monitoring and longitudinal studies to clarify metabolic and cardiovascular implications. These subgroup trends should be interpreted with caution given the absence of BMI, liver enzyme, fibrosis, medication, and comorbidity data in this retrospective cohort.
- Open Access
Analysis of Inflammatory and Thyroid Hormone Levels Based on Hepatitis A and B Virus Immunity Status: Age and Sex Stratification
This study investigated the potential associations between hepatitis virus antibody status and thyroid and inflammatory function. The C-reactive protein (CRP), thyroid-stimulating hormone (TSH), and free thyroxine (FT4) levels were measured in individuals with and without antibodies to the hepatitis A virus (HAV) and hepatitis B virus (HBV). Participants were stratified by age, sex, and HAV/HBV antibody status. Participants with and without antibodies to HAV and HBV had normal CRP, TSH, and FT4 levels. However, notable discrepancies were observed in FT4 levels among participants with HAV antibodies and in CRP and FT4 levels among those with both HAV and HBV antibodies, suggesting potential associations between viral immunity and thyroid function, especially in younger participants. Significant variations in thyroid hormone levels were noted when the sample was stratified by sex and HAV and HBV antibody status, indicating that the association between antibody status and thyroid hormone levels varied by sex. This study underscores the need for further research on the effect of viral immunity on inflammatory parameters and thyroid hormone levels.
Open AccessAnalysis of Inflammatory and Thyroid Hormone Levels Based on Hepatitis A and B Virus Immunity Status: Age and Sex Stratification
This study investigated the potential associations between hepatitis virus antibody status and thyroid and inflammatory function. The C-reactive protein (CRP), thyroid-stimulating hormone (TSH), and free thyroxine (FT4) levels were measured in individuals with and without antibodies to the hepatitis A virus (HAV) and hepatitis B virus (HBV). Participants were stratified by age, sex, and HAV/HBV antibody status. Participants with and without antibodies to HAV and HBV had normal CRP, TSH, and FT4 levels. However, notable discrepancies were observed in FT4 levels among participants with HAV antibodies and in CRP and FT4 levels among those with both HAV and HBV antibodies, suggesting potential associations between viral immunity and thyroid function, especially in younger participants. Significant variations in thyroid hormone levels were noted when the sample was stratified by sex and HAV and HBV antibody status, indicating that the association between antibody status and thyroid hormone levels varied by sex. This study underscores the need for further research on the effect of viral immunity on inflammatory parameters and thyroid hormone levels.
- Open Access
- 15 November 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (22) , 3449
A Comparative Evaluation of HbA1c Measurement Methods and Their Implications for Diabetes Management
In this study, we assessed the correlations between hemoglobin A1c (HbA1c) measurements obtained using three different diagnostic methods, namely reversed-phase cation-exchange chromatography, high-performance liquid chromatography, and lateral flow immunoassay (LIFA) with an AnyLab F instrument. HbA1c levels measured with the AnyLab F instrument and those measured with the HA8190V, HA8180, and D100 instruments were strongly correlated. High R-square values and low p-values indicated significant and reliable correlations, supporting the clinical interchangeability of these methods. Notably, demographic and clinical analyses revealed uniform HbA1c levels across age groups, suggesting minimal age-related variations in HbA1c levels in the cohort. This finding has implications for diabetes management strategies across different age groups, emphasizing the versatility of the AnyLab F instrument. Overall an average HbA1c level of 7.857% among diabetes mellitus-diagnosed participants suggests moderately elevated HbA1c levels, underscoring the need for improved diabetes management. Younger individuals exhibited lower HbA1c levels, potentially owing to heightened awareness and treatment plan adherence. Conversely, older adults had higher HbA1c levels, likely influenced by age-related changes and comorbidities. Larger sample sizes and a comprehensive evaluation of various measurement principles are needed to strengthen the findings herein. Additionally, exploring additional biomarkers and assessing LIFA performance in larger sample sets will advance the clinical utility of HbA1c measurements.
- 15 November 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (22) , 3449
Open AccessA Comparative Evaluation of HbA1c Measurement Methods and Their Implications for Diabetes Management
In this study, we assessed the correlations between hemoglobin A1c (HbA1c) measurements obtained using three different diagnostic methods, namely reversed-phase cation-exchange chromatography, high-performance liquid chromatography, and lateral flow immunoassay (LIFA) with an AnyLab F instrument. HbA1c levels measured with the AnyLab F instrument and those measured with the HA8190V, HA8180, and D100 instruments were strongly correlated. High R-square values and low p-values indicated significant and reliable correlations, supporting the clinical interchangeability of these methods. Notably, demographic and clinical analyses revealed uniform HbA1c levels across age groups, suggesting minimal age-related variations in HbA1c levels in the cohort. This finding has implications for diabetes management strategies across different age groups, emphasizing the versatility of the AnyLab F instrument. Overall an average HbA1c level of 7.857% among diabetes mellitus-diagnosed participants suggests moderately elevated HbA1c levels, underscoring the need for improved diabetes management. Younger individuals exhibited lower HbA1c levels, potentially owing to heightened awareness and treatment plan adherence. Conversely, older adults had higher HbA1c levels, likely influenced by age-related changes and comorbidities. Larger sample sizes and a comprehensive evaluation of various measurement principles are needed to strengthen the findings herein. Additionally, exploring additional biomarkers and assessing LIFA performance in larger sample sets will advance the clinical utility of HbA1c measurements.